Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion

被引:84
作者
Ou, Wu [1 ]
Silver, Jonathan [1 ]
机构
[1] NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA
关键词
HIV-1; fusion; protein disulfide isomerase; thioredoxin siRNA;
D O I
10.1016/j.virol.2006.01.041
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cell-surface protein disulfide isomerase (PDI) has been proposed to promote disulfide bond rearrangements in HIV-1 envelope protein (Env) that accompany Env-mediated fusion. We evaluated the role of PDI in ways that have not been previously tested by downregulating PDI with siRNA and by overexpressing wild-type or variant forms of PDI in transiently and stably transfected cells. These manipulations, as well as treatment with anti-PDI antibodies, had only small effects on infection or cell fusion mediated by NL4-3 or AD8 strains of HIV-1. However, the cell-surface thiol-reactive reagent 5, 5 '-dithiobis(2-nitrobenzoic acid) (DTNB) had a much stronger inhibitory effect in our system, suggesting that cell-surface thiol-containing molecules other than PDI, acting alone or in concert, have a greater effect than PDI on HIV-1 Env-mediated fusion. We evaluated one such candidate, thioredoxin, a PDI family member reported to reduce a labile disulfide bond in CD4. We found that the ability of thioredoxin to reduce the disulfide bond in CD4 is enhanced in the presence of HIV-1 Env gp120 and that thioredoxin also reduces disulfide bonds in gp120 directly in the absence of CD4. We discuss the implications of these observations for identification of molecules involved in disulfide rearrangements in Env during fusion. Published by Elsevier Inc.
引用
收藏
页码:406 / 417
页数:12
相关论文
共 41 条
  • [1] Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env
    Barbouche, R
    Lortat-Jacob, H
    Jones, IM
    Fenouillet, E
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (04) : 1111 - 1118
  • [2] Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion
    Barbouche, R
    Miquelis, R
    Jones, IM
    Fenouillet, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) : 3131 - 3136
  • [3] VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES
    CONNOR, RI
    CHEN, BK
    CHOE, S
    LANDAU, NR
    [J]. VIROLOGY, 1995, 206 (02) : 935 - 944
  • [4] Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
    Derdeyn, CA
    Decker, JM
    Sfakianos, JN
    Wu, XY
    O'Brien, WA
    Ratner, L
    Kappes, JC
    Shaw, GM
    Hunter, E
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (18) : 8358 - 8367
  • [5] A polyclonal antibody to protein disulfide isomerase induces platelet aggregation and secretion
    Essex, DW
    Li, MR
    [J]. THROMBOSIS RESEARCH, 1999, 96 (06) : 445 - 450
  • [6] A SYNCYTIA ASSAY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-I (HIV-I) ENVELOPE PROTEIN AND ITS USE IN STUDYING HIV-I MUTATIONS
    FELSER, JM
    KLIMKAIT, T
    SILVER, J
    [J]. VIROLOGY, 1989, 170 (02) : 566 - 570
  • [7] The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope- mediated membrane fusion after CD4 cell binding
    Fenouillet, E
    Barbouche, R
    Courageot, J
    Miquelis, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (05) : 744 - 752
  • [8] Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry
    Gallina, A
    Hanley, TM
    Mandel, R
    Trahey, M
    Broder, CC
    Viglianti, GA
    Ryser, HJP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) : 50579 - 50588
  • [9] The HIV Env-mediated fusion reaction
    Gallo, SA
    Finnegan, CM
    Viard, M
    Raviv, Y
    Dimitrov, A
    Rawat, SS
    Puri, A
    Durell, S
    Blumenthal, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1614 (01): : 36 - 50
  • [10] ESCHERICHIA-COLI EXPRESSION, PURIFICATION, AND BIOLOGICAL-ACTIVITY OF A TRUNCATED SOLUBLE CD4
    GARLICK, RL
    KIRSCHNER, RJ
    ECKENRODE, FM
    TARPLEY, WG
    TOMICH, CSC
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (04) : 465 - 479